Sub Category
Study Name
NSABP B-43:A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
Patient's tumor must be ductal carcinoma in situ (DCIS) Must be HER2 positive Estrogen &/or progesterone receptor status must be determined
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance